5:17 PM
 | 
Jan 17, 2013
 |  BC Extra  |  Financial News

Trius proposes follow-on

Trius Therapeutics Inc. (NASDAQ:TSRX) said late Thursday that it is planning a follow-on underwritten by Citigroup; Leerink; and...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >